These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 14528077)

  • 1. Renal medullary carcinoma: case report and review of the literature.
    Noguera-Irizarry WG; Hibshoosh H; Papadopoulos KP
    Am J Clin Oncol; 2003 Oct; 26(5):489-92. PubMed ID: 14528077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose-intensity MVAC for Advanced Renal Medullary Carcinoma: Report of Three Cases and Literature Review.
    Rathmell WK; Monk JP
    Urology; 2008 Sep; 72(3):659-63. PubMed ID: 18649931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival of a patient with sickle cell trait and metastatic renal medullary carcinoma.
    Pirich LM; Chou P; Walterhouse DO
    J Pediatr Hematol Oncol; 1999; 21(1):67-9. PubMed ID: 10029817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal pelvic tumor in chronic renal failure: report of a case].
    Kojima Y; Uchida K; Takiuchi H; Wakatsuki A; Sakurai T; Ochi S; Shirai D; Kobayashi Y
    Hinyokika Kiyo; 1990 May; 36(5):587-91. PubMed ID: 2205088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
    Long HJ; Nelimark RA; Podratz KC; Suman V; Keeney GL; Nikcevich DA; Kugler JW; Rowland KM; Kardinal CG; Wos EJ
    Gynecol Oncol; 2006 Mar; 100(3):501-5. PubMed ID: 16185755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancer.
    Chehal A; Taher A; Khalil M; Shamseddine A
    Breast; 2004 Oct; 13(5):421-4. PubMed ID: 15454199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium.
    Dreicer R; Manola J; Roth BJ; See WA; Kuross S; Edelman MJ; Hudes GR; Wilding G
    Cancer; 2004 Apr; 100(8):1639-45. PubMed ID: 15073851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal medullary carcinoma as an incidental finding in a horseshoe kidney: case report and literature review.
    Molgat G; Afrouzian M; Trpkov K
    Can J Urol; 2005 Oct; 12(5):2837-40. PubMed ID: 16274520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcome of treatment with surgical resection of the remaining tumor after modified M-VAC treatment for advanced urothelial carcinoma].
    Narita S; Nakano M; Matsuzaki M; Watanabe J; Morikawa H; Murata H; Oda H; Komatsu H
    Hinyokika Kiyo; 2005 Mar; 51(3):155-8. PubMed ID: 15852667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs].
    Okumura S; Nishimura T; Yoshida K; Ohhara M; Hasegawa J; Hirasawa S; Hara M; Kawamura N; Kanamori S; Akimoto M
    Hinyokika Kiyo; 1984 Sep; 30(9):1167-71. PubMed ID: 6084420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bellini duct carcinoma of kidney with invasive growth pattern: a case report].
    Jinza S; Asakura T; Takase K; Misaki H; Satomi Y; Nagashima Y
    Hinyokika Kiyo; 1997 Apr; 43(4):291-4. PubMed ID: 9161859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Squamous cell carcinoma of the renal pelvis with elevation of G-CSF in the serum: a case report].
    Fujii H; Nakamura T; Mikami K; Okihara K; Mizutani Y; Kawauchi A; Miki T
    Hinyokika Kiyo; 2008 Nov; 54(11):733-6. PubMed ID: 19068728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic features of renal medullary carcinoma.
    Assad L; Resetkova E; Oliveira VL; Sun W; Stewart JM; Katz RL; Caraway NP
    Cancer; 2005 Feb; 105(1):28-34. PubMed ID: 15593260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal medullary carcinoma.
    Baig MA; Lin YS; Rasheed J; Mittman N
    J Natl Med Assoc; 2006 Jul; 98(7):1171-4. PubMed ID: 16895289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.
    Gangireddy Vg; Liles GB; Sostre GD; Coleman T
    Clin Genitourin Cancer; 2012 Jun; 10(2):134-9. PubMed ID: 22409864
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of cisplatin and methotrexate after M-VAC chemotherapy for advanced urothelial cancer in hemodialysis patients.
    Matsumoto K
    Int J Urol; 2008 Oct; 15(10):949-50. PubMed ID: 19138292
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
    Hatano K; Kawashima A; Arai Y; Inoue H; Miyagawa Y; Takaha N; Nishimura K; Miyake O; Okuyama A
    Hinyokika Kiyo; 2006 Oct; 52(10):801-3. PubMed ID: 17131872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.
    Long HJ; Monk BJ; Huang HQ; Grendys EC; McMeekin DS; Sorosky J; Miller DS; Eaton LA; Fiorica JV;
    Gynecol Oncol; 2006 Mar; 100(3):537-43. PubMed ID: 16216315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
    Yamada Y; Itoh Y; Aoki S; Nakamura K; Taki T; Naruse K; Tobiume M; Zennami K; Katsuda R; Kato Y; Watanabe M; Nishikawa G; Minami M; Nakahira M; Ukai S; Sawada M; Kitamura A; Honda N
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1079-83. PubMed ID: 19277660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.